Abstract
Hypertrophic cardiomyopathy is inherited as an autosomal dominant trait and can be diagnosed during pregnancy. Cardiomyopathy is the leading cause of nonobstetric maternal morbidity and mortality. We present the case of a 26-year-old pregnant woman with hypertrophic cardiomyopathy and an automatic implantable cardioverter defibrillator and we discuss the most important therapeutic considerations in the management of these patients before and during delivery and in the immediate postpartum period.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
